CN109761868A - 一种光学纯氯前列醇的合成方法 - Google Patents
一种光学纯氯前列醇的合成方法 Download PDFInfo
- Publication number
- CN109761868A CN109761868A CN201910082598.6A CN201910082598A CN109761868A CN 109761868 A CN109761868 A CN 109761868A CN 201910082598 A CN201910082598 A CN 201910082598A CN 109761868 A CN109761868 A CN 109761868A
- Authority
- CN
- China
- Prior art keywords
- cloprostenol
- reaction
- compound
- synthetic method
- optical voidness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VJGGHXVGBSZVMZ-QIZQQNKQSA-N Cloprostenol Chemical compound C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(Cl)=C1 VJGGHXVGBSZVMZ-QIZQQNKQSA-N 0.000 title claims abstract description 35
- 229960004409 cloprostenol Drugs 0.000 title claims abstract description 35
- 230000003287 optical effect Effects 0.000 title claims abstract description 24
- 238000010189 synthetic method Methods 0.000 title claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 52
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 238000006772 olefination reaction Methods 0.000 claims abstract description 9
- 230000020477 pH reduction Effects 0.000 claims abstract description 9
- 238000001953 recrystallisation Methods 0.000 claims abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 75
- 239000000243 solution Substances 0.000 claims description 38
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 34
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 31
- 238000001914 filtration Methods 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 26
- 238000001035 drying Methods 0.000 claims description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 16
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 13
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 11
- 238000002425 crystallisation Methods 0.000 claims description 10
- 230000008025 crystallization Effects 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims description 10
- 238000007239 Wittig reaction Methods 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 6
- YSNGTNPJJSRPHQ-UHFFFAOYSA-N C1C(C2)C3CC2(C)N([O])C1(C)C3 Chemical compound C1C(C2)C3CC2(C)N([O])C1(C)C3 YSNGTNPJJSRPHQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000007800 oxidant agent Substances 0.000 claims description 6
- 230000001590 oxidative effect Effects 0.000 claims description 6
- 150000002596 lactones Chemical class 0.000 claims description 5
- -1 phosphonate ester Chemical class 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 claims description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 4
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 claims description 4
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 claims description 3
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 3
- DORMTBIPKNPJPY-UHFFFAOYSA-N acetic acid;iodobenzene Chemical class CC(O)=O.IC1=CC=CC=C1 DORMTBIPKNPJPY-UHFFFAOYSA-N 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 2
- OBTZDIRUQWFRFZ-UHFFFAOYSA-N 2-(5-methylfuran-2-yl)-n-(4-methylphenyl)quinoline-4-carboxamide Chemical compound O1C(C)=CC=C1C1=CC(C(=O)NC=2C=CC(C)=CC=2)=C(C=CC=C2)C2=N1 OBTZDIRUQWFRFZ-UHFFFAOYSA-N 0.000 claims 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- BCJCJALHNXSXKE-UHFFFAOYSA-N azado Chemical compound C1C(C2)CC3CC1N([O])C2C3 BCJCJALHNXSXKE-UHFFFAOYSA-N 0.000 claims 1
- 150000002240 furans Chemical class 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 abstract description 14
- 238000002360 preparation method Methods 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 238000007867 post-reaction treatment Methods 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- 239000012074 organic phase Substances 0.000 description 20
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000012071 phase Substances 0.000 description 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 235000019439 ethyl acetate Nutrition 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000003810 ethyl acetate extraction Methods 0.000 description 9
- 238000013517 stratification Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000003963 dichloro group Chemical group Cl* 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OKUSWAGOKUGEDX-UHFFFAOYSA-N C(CCC)Br(CCCC)(CCCC)CCCC Chemical compound C(CCC)Br(CCCC)(CCCC)CCCC OKUSWAGOKUGEDX-UHFFFAOYSA-N 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- KZIBQYUFIVUOHY-UHFFFAOYSA-N bis(2-methylpropyl)alumane toluene Chemical compound Cc1ccccc1.[H][Al](CC(C)C)CC(C)C KZIBQYUFIVUOHY-UHFFFAOYSA-N 0.000 description 1
- SXGBREZGMJVYRL-UHFFFAOYSA-N butan-1-amine;hydrobromide Chemical compound [Br-].CCCC[NH3+] SXGBREZGMJVYRL-UHFFFAOYSA-N 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 201000006381 corpus luteum cyst Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910082598.6A CN109761868B (zh) | 2019-01-28 | 2019-01-28 | 一种光学纯氯前列醇的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910082598.6A CN109761868B (zh) | 2019-01-28 | 2019-01-28 | 一种光学纯氯前列醇的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109761868A true CN109761868A (zh) | 2019-05-17 |
CN109761868B CN109761868B (zh) | 2020-04-17 |
Family
ID=66455552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910082598.6A Active CN109761868B (zh) | 2019-01-28 | 2019-01-28 | 一种光学纯氯前列醇的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109761868B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110483360A (zh) * | 2019-09-10 | 2019-11-22 | 河南美森药业有限公司 | 一种阿法前列醇的合成方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4079055A (en) * | 1975-06-11 | 1978-03-14 | Imperial Chemical Industries Limited | Chemical reduction process |
US20100105775A1 (en) * | 2008-10-29 | 2010-04-29 | Delong Mitchell A | Amino acid salts of prostaglandins |
US20150011755A1 (en) * | 2012-02-07 | 2015-01-08 | Dr. Reddys Laboratories Limited | Amine salts of prostaglandin analogs |
CN104513186A (zh) * | 2015-01-13 | 2015-04-15 | 宁波第二激素厂 | 一种光学纯的右旋氯前列醇钠的制备方法 |
CN106810484A (zh) * | 2016-12-28 | 2017-06-09 | 宁波第二激素厂 | 氨基丁三醇前列腺素F2α的合成方法 |
CN108084074A (zh) * | 2017-12-25 | 2018-05-29 | 厦门欧瑞捷生物科技有限公司 | 一种简便高效合成地诺前列素的方法 |
-
2019
- 2019-01-28 CN CN201910082598.6A patent/CN109761868B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4079055A (en) * | 1975-06-11 | 1978-03-14 | Imperial Chemical Industries Limited | Chemical reduction process |
US20100105775A1 (en) * | 2008-10-29 | 2010-04-29 | Delong Mitchell A | Amino acid salts of prostaglandins |
US20150011755A1 (en) * | 2012-02-07 | 2015-01-08 | Dr. Reddys Laboratories Limited | Amine salts of prostaglandin analogs |
CN104513186A (zh) * | 2015-01-13 | 2015-04-15 | 宁波第二激素厂 | 一种光学纯的右旋氯前列醇钠的制备方法 |
CN106810484A (zh) * | 2016-12-28 | 2017-06-09 | 宁波第二激素厂 | 氨基丁三醇前列腺素F2α的合成方法 |
CN108084074A (zh) * | 2017-12-25 | 2018-05-29 | 厦门欧瑞捷生物科技有限公司 | 一种简便高效合成地诺前列素的方法 |
Non-Patent Citations (2)
Title |
---|
裴颖: "鲁比前列酮合成工艺研究", 《临床医药文献杂志》 * |
高怡生 等主编: "《生育调节剂合成化学新进展》", 4 November 1981 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110483360A (zh) * | 2019-09-10 | 2019-11-22 | 河南美森药业有限公司 | 一种阿法前列醇的合成方法 |
CN110483360B (zh) * | 2019-09-10 | 2021-01-01 | 河南美森药业有限公司 | 一种阿法前列醇的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109761868B (zh) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102295672B (zh) | 一种泰拉菌素的合成方法 | |
CN105061373B (zh) | 一种达格列净异构体杂质的合成方法 | |
CN105601524A (zh) | Lcz696关键中间体的制备 | |
CN112062712A (zh) | 一种2-(5-溴-3-甲基吡啶-2-基)乙酸盐酸盐的制备方法 | |
CN108409620A (zh) | 一类联烯三氟甲硫醚衍生物及其合成方法 | |
CN107540574A (zh) | R‑联苯丙氨醇的制备方法 | |
CN109761868A (zh) | 一种光学纯氯前列醇的合成方法 | |
CN102317256A (zh) | 制备消旋卡多曲的方法 | |
CN108892659A (zh) | 一种卡格列净杂质及其制备方法 | |
CN106146457B (zh) | 一种5-氯-2-酰氯噻吩中间体及其制备方法 | |
CN114736151B (zh) | 一种帕罗韦德关键中间体制备方法及化合物的结构式 | |
CN103709132A (zh) | 一种奈必洛尔中间体的制备方法 | |
JP4952272B2 (ja) | (z)−リグスチリドの製造方法 | |
CN108084074B (zh) | 一种简便高效合成地诺前列素的方法 | |
CN108530323A (zh) | 一种2-(2,2-二氟乙氧基)-6-三氟甲基苯磺酰氯的制备方法 | |
CN112125942B (zh) | 醋酸阿比特龙及其中间体的合成方法 | |
CN109553595A (zh) | 一种手性γ-丁内酯的制备方法及其中间体 | |
CN109956948B (zh) | 天然产物(-)-newbouldine的合成方法 | |
CN106588739A (zh) | 一种反‑3‑羟基‑l‑脯氨酸制备方法 | |
CN106565441A (zh) | 一种3,5‑二氯‑2‑戊酮的合成方法 | |
CN107936034B (zh) | 苄氧基二苯并[b,f]噁庚英环丙烯酸类化合物与中间体及其应用 | |
CN105131016A (zh) | 一种头孢呋辛酯的制备方法 | |
CN101597226B (zh) | 6-羟基-1-茚酮的合成方法 | |
CN102395573B (zh) | 2-烷基-3-氨基噻吩衍生物的制造方法 | |
CN108727242A (zh) | 一种降血压药物关键中间体反式-4-环己基-l-脯氨酸的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis of optically pure chloroprostanol Effective date of registration: 20201225 Granted publication date: 20200417 Pledgee: Xiamen finance Company limited by guarantee Pledgor: XIAMEN OURUIJIE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980009948 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231026 Granted publication date: 20200417 Pledgee: Xiamen finance Company limited by guarantee Pledgor: XIAMEN OURUIJIE BIOTECHNOLOGY CO.,LTD. Registration number: Y2020980009948 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic method of optically pure chloroprostanol Granted publication date: 20200417 Pledgee: Industrial and Commercial Bank of China Xiamen Xiang'an Branch Pledgor: XIAMEN OURUIJIE BIOTECHNOLOGY CO.,LTD. Registration number: Y2024980000931 |